Myelin basic protein deficit in the PNS of mld mutant mice recovers during development
- PMID: 6205845
- DOI: 10.1159/000112338
Myelin basic protein deficit in the PNS of mld mutant mice recovers during development
Abstract
Myelination was studied between 15 and 135 days postnatally in peripheral nerves of myelin deficient (mld) mice and in unaffected littermates. The nerve weights were not affected by the mutation and showed a 4-fold increase during the developmental period studied. The amounts of myelin present in peripheral nerves, as shown by biochemical and morphological techniques, were slightly reduced in mld in comparison to control mice. In controls, the concentration of myelin doubled during the investigation period. The increase of myelin basic protein (MBP) in total nerve homogenate paralleled the deposition of myelin, but the MBP concentration remained constant in normal myelin. In contrast, in mld myelin MBP concentrations were extremely low until 60 days of age and increased thereafter to reach almost normal values at 135 days. Similarly, the amounts of myelin isolated at 85 and 135 days were normal. 2',3'-Cyclic nucleotide 3'-phosphodiesterase (CNP; EC 3.1.4.37), the myelin-specific enzyme, showed normal specific activities in mld nerves. In mld and control myelin, CNP-specific activities decreased during development suggesting a preferential localization of CNP in Schwann cell plasma membranes. In contrast to the central nervous system, other myelin proteins were not altered in mld peripheral nervous system (PNS) and the very low MBP content had no severe repercussions on the composition and structure of the myelin sheath. Furthermore, Schwann cells appeared normal in mld PNS. Nevertheless, more subtle alterations could be detected. Slightly decreased amounts of myelin were observed in young mld mice and preliminary results indicate discrete alterations of the myelin periodicity.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
In vitro myelin basic protein synthesis in the PNS and CNS of myelin deficient (mld) mutant mice.Brain Res. 1983 Oct 31;277(2):386-8. doi: 10.1016/0006-8993(83)90952-6. Brain Res. 1983. PMID: 6196085
-
Myelination in the CNS of mld mutant mice: comparison between composition and structure.Brain Res. 1984 Mar;315(1):149-58. doi: 10.1016/0165-3806(84)90086-5. Brain Res. 1984. PMID: 6202376
-
Low myelin basic protein levels and normal myelin in peripheral nerves of myelin deficient mutant mice (MLD).Neuroscience. 1980;5(12):2315-20. doi: 10.1016/0306-4522(80)90147-5. Neuroscience. 1980. PMID: 6162131 No abstract available.
-
Molecular biology of myelin basic protein: gene rearrangement and expression of anti-sense RNA in myelin-deficient mutants.Comp Biochem Physiol C Comp Pharmacol Toxicol. 1991;98(1):51-61. Comp Biochem Physiol C Comp Pharmacol Toxicol. 1991. PMID: 1709079 Review.
-
Neurosteroids, with special reference to the effect of progesterone on myelination in peripheral nerves.Mult Scler. 1997 Apr;3(2):105-12. doi: 10.1177/135245859700300209. Mult Scler. 1997. PMID: 9291163 Review.
Cited by
-
Phosphodiesterase-5 is a therapeutic target for peripheral neuropathy in diabetic mice.Neuroscience. 2011 Oct 13;193:399-410. doi: 10.1016/j.neuroscience.2011.07.039. Epub 2011 Jul 27. Neuroscience. 2011. PMID: 21820491 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous